182 related articles for article (PubMed ID: 36894111)
1. A cross sectional pilot study to assess the role of phthalates on respiratory morbidity among patients with chronic obstructive pulmonary disease.
Quirós-Alcalá L; Belz DC; Woo H; Lorizio W; Putcha N; Koehler K; McCormack MC; Hansel NN
Environ Res; 2023 May; 225():115622. PubMed ID: 36894111
[TBL] [Abstract][Full Text] [Related]
2. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
[TBL] [Abstract][Full Text] [Related]
3. Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease.
Paulin LM; Diette GB; Blanc PD; Putcha N; Eisner MD; Kanner RE; Belli AJ; Christenson S; Tashkin DP; Han M; Barr RG; Hansel NN;
Am J Respir Crit Care Med; 2015 Mar; 191(5):557-65. PubMed ID: 25562375
[TBL] [Abstract][Full Text] [Related]
4. Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers.
Bhatt SP; Terry NL; Nath H; Zach JA; Tschirren J; Bolding MS; Stinson DS; Wilson CG; Curran-Everett D; Lynch DA; Putcha N; Soler X; Wise RA; Washko GR; Hoffman EA; Foreman MG; Dransfield MT;
JAMA; 2016 Feb; 315(5):498-505. PubMed ID: 26836732
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
Tan M; Jian W; Liang Q; Li S; Cui H
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
[TBL] [Abstract][Full Text] [Related]
6. Investigating sensitivity, specificity, and area under the curve of the Clinical COPD Questionnaire, COPD Assessment Test, and Modified Medical Research Council scale according to GOLD using St George's Respiratory Questionnaire cutoff 25 (and 20) as reference.
Tsiligianni IG; Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Schultz K; Kollen BJ; van der Molen T; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2016; 11():1045-52. PubMed ID: 27274226
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
[TBL] [Abstract][Full Text] [Related]
8. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
[TBL] [Abstract][Full Text] [Related]
9. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
[TBL] [Abstract][Full Text] [Related]
10. Utility of the CAT in the therapy assessment of COPD exacerbations in China.
Tu YH; Zhang Y; Fei GH
BMC Pulm Med; 2014 Mar; 14():42. PubMed ID: 24618290
[TBL] [Abstract][Full Text] [Related]
11. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.
Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450
[TBL] [Abstract][Full Text] [Related]
12. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
[TBL] [Abstract][Full Text] [Related]
13. Phthalate biomarkers and associations with respiratory symptoms and healthcare utilization among low-income urban children with asthma.
Fandiño-Del-Rio M; Matsui EC; Peng RD; Meeker JD; Quirós-Alcalá L
Environ Res; 2022 Sep; 212(Pt B):113239. PubMed ID: 35405131
[TBL] [Abstract][Full Text] [Related]
14. Assessing health status over time: impact of recall period and anchor question on the minimal clinically important difference of copd health status tools.
Alma HJ; de Jong C; Jelusic D; Wittmann M; Schuler M; Kollen BJ; Sanderman R; Schultz K; Kocks JWH; Van der Molen T
Health Qual Life Outcomes; 2018 Jun; 16(1):130. PubMed ID: 29940980
[TBL] [Abstract][Full Text] [Related]
15. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
[TBL] [Abstract][Full Text] [Related]
16. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
[TBL] [Abstract][Full Text] [Related]
17. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
[TBL] [Abstract][Full Text] [Related]
18. Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study.
Cho J; Lee CH; Kim DK; Hwang HG; Kim YI; Choi HS; Park JW; Yoo KH; Jung KS; Lee SD;
Korean J Intern Med; 2020 Sep; 35(5):1154-1163. PubMed ID: 32098456
[TBL] [Abstract][Full Text] [Related]
19. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
Giezeman M; Hasselgren M; Lisspers K; Ställberg B; Montgomery S; Janson C; Sundh J
Int J Chron Obstruct Pulmon Dis; 2018; 13():3857-3865. PubMed ID: 30568437
[TBL] [Abstract][Full Text] [Related]
20. Clinical phenotypes and heath-related quality of life of COPD patients in a rural setting in Malaysia - a cross-sectional study.
Chai CS; Mos SB; Ng DL; Goh GM; Su AT; Ibrahim MAB; Musa ANB; Tan SB; Pang YK; Liam CK
BMC Pulm Med; 2020 Sep; 20(1):254. PubMed ID: 32993591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
